Sesen Bio Announces Changes to the Board of Directors as the Company Advances Toward Commercialization of Vicinium® - Yahoo! Finance -BoardProspects

Sesen Bio Announces Changes to the Board of Directors as the Company Advances Toward Commercialization of Vicinium®

Yahoo! Finance Feb 25 2020 BoardMoves

Sesen Bio (Nasdaq: SESN) a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced the appointment of Carrie Bourdow, chief executive officer of Trevena, Inc., and Jason Keyes, chief financial officer of Equillium, to the Company’s Board of Directors...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Boeing CFO Joins JPMorgan Board also categorized in BoardMoves
- Qualcomm co-founder to retire from board in 2012 also categorized in BoardMoves
- Yahoo! Names Thompson CEO also categorized in BoardMoves
- Molson Coors Adds Two to Board also categorized in BoardMoves
- Thompson Joins Microsoft Board also categorized in BoardMoves
- New CEO and Board Research from Stanford and The Miles Group: In Grading CEO Performance, Financials Still Dominate also published in Yahoo! Finance
- KKR representatives resign from Kodak's board also categorized in BoardMoves
- A New Diversity Monitor for the S.E.C. - NYTimes.com also categorized in BoardMoves
- Time Inc. Appoints Griffin CEO also categorized in BoardMoves
- Microsoft Adds New Board Member also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned
- activist investor
- Nasdaq
- AMP
- Fusion
- Target
- Sesen Bio
- Carrie Bourdow